APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Methotrexate Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Methotrexate Injection Market Analysis and Forecast 2026-2032

Report ID 17401281022 January 2026198 pages

Choose your research edition.

Industry ResearchMethotrexate Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Methotrexate Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methotrexate Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Methotrexate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methotrexate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Methotrexate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Methotrexate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Methotrexate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Methotrexate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Methotrexate Injection include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Methotrexate Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Methotrexate Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Methotrexate Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Methotrexate Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Methotrexate Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Methotrexate Injection sales, projected growth trends, production technology, application and end-user industry.

Methotrexate Injection Segment by Company

Accord

Get Well Pharmaceutical

Hikma

Fresenius Kabi

Guangdong Lingnan Pharma

Hengrui Medicine

Pfizer

Mylan

Qilu Pharmaceutical

Shanxi Pude Pharma

Sichuan Huiyu Pharma

Teva

Youcare Pharmaceutical Group

Methotrexate Injection Segment by Type

Preservative-Free

With Preservative

Methotrexate Injection Segment by Application

Specialty Clinic

Hospital

Recovry Center

Methotrexate Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Methotrexate Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methotrexate Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Methotrexate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Preservative-Free Major Manufacturers Table 3. With Preservative Major Manufacturers Table 4. Global Methotrexate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Specialty Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Recovry Center Major Manufacturers Table 8. Methotrexate Injection Industry Trends Table 9. Methotrexate Injection Industry Drivers Table 10. Methotrexate Injection Industry Opportunities and Challenges Table 11. Methotrexate Injection Industry Restraints Table 12. Global Methotrexate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Methotrexate Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Methotrexate Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Methotrexate Injection Revenue Market Share by Region (2021-2026) Table 16. Global Methotrexate Injection Revenue Market Share by Region (2027-2032) Table 17. Global Methotrexate Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Methotrexate Injection Sales by Region (2021-2026) & (W Units) Table 19. Global Methotrexate Injection Sales by Region (2027-2032) & (W Units) Table 20. Global Methotrexate Injection Sales Market Share by Region (2021-2026) Table 21. Global Methotrexate Injection Sales Market Share by Region (2027-2032) Table 22. Global Methotrexate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Methotrexate Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Methotrexate Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Methotrexate Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Methotrexate Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Methotrexate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Methotrexate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Methotrexate Injection Manufacturers, Product Type & Application Table 30. Global Methotrexate Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Methotrexate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Methotrexate Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Methotrexate Injection Revenue Market Share by Type (2021-2026) Table 37. Global Methotrexate Injection Revenue Market Share by Type (2027-2032) Table 38. Global Methotrexate Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 40. Global Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 41. Global Methotrexate Injection Sales Market Share by Type (2021-2026) Table 42. Global Methotrexate Injection Sales Market Share by Type (2027-2032) Table 43. Global Methotrexate Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Methotrexate Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Methotrexate Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Methotrexate Injection Revenue Market Share by Application (2021-2026) Table 49. Global Methotrexate Injection Revenue Market Share by Application (2027-2032) Table 50. Global Methotrexate Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 52. Global Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 53. Global Methotrexate Injection Sales Market Share by Application (2021-2026) Table 54. Global Methotrexate Injection Sales Market Share by Application (2027-2032) Table 55. Global Methotrexate Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Methotrexate Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Accord Company Information Table 58. Accord Business Overview Table 59. Accord Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Accord Methotrexate Injection Product Portfolio Table 61. Accord Recent Development Table 62. Get Well Pharmaceutical Company Information Table 63. Get Well Pharmaceutical Business Overview Table 64. Get Well Pharmaceutical Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Get Well Pharmaceutical Methotrexate Injection Product Portfolio Table 66. Get Well Pharmaceutical Recent Development Table 67. Hikma Company Information Table 68. Hikma Business Overview Table 69. Hikma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Hikma Methotrexate Injection Product Portfolio Table 71. Hikma Recent Development Table 72. Fresenius Kabi Company Information Table 73. Fresenius Kabi Business Overview Table 74. Fresenius Kabi Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Fresenius Kabi Methotrexate Injection Product Portfolio Table 76. Fresenius Kabi Recent Development Table 77. Guangdong Lingnan Pharma Company Information Table 78. Guangdong Lingnan Pharma Business Overview Table 79. Guangdong Lingnan Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio Table 81. Guangdong Lingnan Pharma Recent Development Table 82. Hengrui Medicine Company Information Table 83. Hengrui Medicine Business Overview Table 84. Hengrui Medicine Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hengrui Medicine Methotrexate Injection Product Portfolio Table 86. Hengrui Medicine Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Methotrexate Injection Product Portfolio Table 91. Pfizer Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mylan Methotrexate Injection Product Portfolio Table 96. Mylan Recent Development Table 97. Qilu Pharmaceutical Company Information Table 98. Qilu Pharmaceutical Business Overview Table 99. Qilu Pharmaceutical Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Qilu Pharmaceutical Methotrexate Injection Product Portfolio Table 101. Qilu Pharmaceutical Recent Development Table 102. Shanxi Pude Pharma Company Information Table 103. Shanxi Pude Pharma Business Overview Table 104. Shanxi Pude Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shanxi Pude Pharma Methotrexate Injection Product Portfolio Table 106. Shanxi Pude Pharma Recent Development Table 107. Sichuan Huiyu Pharma Company Information Table 108. Sichuan Huiyu Pharma Business Overview Table 109. Sichuan Huiyu Pharma Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio Table 111. Sichuan Huiyu Pharma Recent Development Table 112. Teva Company Information Table 113. Teva Business Overview Table 114. Teva Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Teva Methotrexate Injection Product Portfolio Table 116. Teva Recent Development Table 117. Youcare Pharmaceutical Group Company Information Table 118. Youcare Pharmaceutical Group Business Overview Table 119. Youcare Pharmaceutical Group Methotrexate Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio Table 121. Youcare Pharmaceutical Group Recent Development Table 122. North America Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 125. North America Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 126. North America Methotrexate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Methotrexate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 131. North America Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 132. North America Methotrexate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Methotrexate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Methotrexate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Methotrexate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 138. North America Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 139. North America Methotrexate Injection Sales by Country (2027-2032) & (W Units) Table 140. North America Methotrexate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Methotrexate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 143. Canada Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 144. Europe Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 147. Europe Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 148. Europe Methotrexate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Europe Methotrexate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Europe Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 153. Europe Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 154. Europe Methotrexate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Europe Methotrexate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Europe Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Methotrexate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Methotrexate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 160. Europe Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 161. Europe Methotrexate Injection Sales by Country (2027-2032) & (W Units) Table 162. Europe Methotrexate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Europe Methotrexate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Germany Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 165. France Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 166. U.K. Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 167. Italy Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 169. Nordic Countries Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 170. China Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 171. China Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 172. China Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 173. China Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 174. China Methotrexate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Methotrexate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 177. China Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 178. China Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 179. China Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 180. China Methotrexate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Methotrexate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 185. Asia Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 186. Asia Methotrexate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Methotrexate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 191. Asia Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 192. Asia Methotrexate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Methotrexate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Methotrexate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Methotrexate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 198. Asia Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 199. Asia Methotrexate Injection Sales by Country (2027-2032) & (W Units) Table 200. Asia Methotrexate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Methotrexate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 203. South Korea Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 204. India Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 205. Australia Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Methotrexate Injection Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Methotrexate Injection Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Methotrexate Injection Sales by Type (2021-2026) & (W Units) Table 211. SAMEA Methotrexate Injection Sales by Type (2027-2032) & (W Units) Table 212. SAMEA Methotrexate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Methotrexate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Methotrexate Injection Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Methotrexate Injection Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Methotrexate Injection Sales by Application (2021-2026) & (W Units) Table 217. SAMEA Methotrexate Injection Sales by Application (2027-2032) & (W Units) Table 218. SAMEA Methotrexate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Methotrexate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Methotrexate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Methotrexate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 224. SAMEA Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 225. SAMEA Methotrexate Injection Sales by Country (2027-2032) & (W Units) Table 226. SAMEA Methotrexate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Methotrexate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 229. Argentina Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 230. Chile Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 231. Colombia Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 232. Peru Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 234. Israel Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 235. UAE Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 236. Turkey Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 237. Iran Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 238. Egypt Methotrexate Injection Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Methotrexate Injection Distributors List Table 242. Methotrexate Injection Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Methotrexate Injection Image Figure 2. Global Methotrexate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methotrexate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Preservative-Free Image Figure 5. With Preservative Image Figure 6. Global Methotrexate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Methotrexate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Specialty Clinic Image Figure 9. Hospital Image Figure 10. Recovry Center Image Figure 11. Global Methotrexate Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Methotrexate Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Methotrexate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Methotrexate Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Methotrexate Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Methotrexate Injection Sales (2021-2032) & (W Units) Figure 17. Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Methotrexate Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Methotrexate Injection Sales YoY (2021-2032) & (W Units) Figure 20. Europe Methotrexate Injection Sales YoY (2021-2032) & (W Units) Figure 21. China Methotrexate Injection Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Methotrexate Injection Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Methotrexate Injection Sales YoY (2021-2032) & (W Units) Figure 24. Global Methotrexate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Methotrexate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Methotrexate Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Methotrexate Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Methotrexate Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Methotrexate Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Methotrexate Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Methotrexate Injection Sales Market Share by Type (2021-2032) Figure 33. Global Methotrexate Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Methotrexate Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Methotrexate Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Methotrexate Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Methotrexate Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Methotrexate Injection Sales Market Share by Application (2021-2032) Figure 39. North America Methotrexate Injection Revenue Share by Type (2021-2032) Figure 40. North America Methotrexate Injection Sales Share by Type (2021-2032) Figure 41. North America Methotrexate Injection Revenue Share by Application (2021-2032) Figure 42. North America Methotrexate Injection Sales Share by Application (2021-2032) Figure 43. North America Methotrexate Injection Revenue Share by Country (2021-2032) Figure 44. North America Methotrexate Injection Sales Share by Country (2021-2032) Figure 45. Europe Methotrexate Injection Revenue Share by Type (2021-2032) Figure 46. Europe Methotrexate Injection Sales Share by Type (2021-2032) Figure 47. Europe Methotrexate Injection Revenue Share by Application (2021-2032) Figure 48. Europe Methotrexate Injection Sales Share by Application (2021-2032) Figure 49. Europe Methotrexate Injection Revenue Share by Country (2021-2032) Figure 50. Europe Methotrexate Injection Sales Share by Country (2021-2032) Figure 51. China Methotrexate Injection Revenue Share by Type (2021-2032) Figure 52. China Methotrexate Injection Sales Share by Type (2021-2032) Figure 53. China Methotrexate Injection Revenue Share by Application (2021-2032) Figure 54. China Methotrexate Injection Sales Share by Application (2021-2032) Figure 55. Asia Methotrexate Injection Revenue Share by Type (2021-2032) Figure 56. Asia Methotrexate Injection Sales Share by Type (2021-2032) Figure 57. Asia Methotrexate Injection Revenue Share by Application (2021-2032) Figure 58. Asia Methotrexate Injection Sales Share by Application (2021-2032) Figure 59. Asia Methotrexate Injection Revenue Share by Country (2021-2032) Figure 60. Asia Methotrexate Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Methotrexate Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Methotrexate Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Methotrexate Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Methotrexate Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Methotrexate Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Methotrexate Injection Sales Share by Country (2021-2032) Figure 67. Methotrexate Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Methotrexate Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Preservative-Free
  • With Preservative
Applications
  • Specialty Clinic
  • Hospital
  • Recovry Center
Companies covered
  • Accord
  • Get Well Pharmaceutical
  • Hikma
  • Fresenius Kabi
  • Guangdong Lingnan Pharma
  • Hengrui Medicine
  • Pfizer
  • Mylan
  • Qilu Pharmaceutical
  • Shanxi Pude Pharma
  • Sichuan Huiyu Pharma
  • Teva
  • Youcare Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Methotrexate Injection Market by Type
  3. 1.2.1 Global Methotrexate Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Preservative-Free
  5. 1.2.3 With Preservative
  6. 1.3 Methotrexate Injection Market by Application
  7. 1.3.1 Global Methotrexate Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Specialty Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Recovry Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Methotrexate Injection Market Dynamics
  1. 2.1 Methotrexate Injection Industry Trends
  2. 2.2 Methotrexate Injection Industry Drivers
  3. 2.3 Methotrexate Injection Industry Opportunities and Challenges
  4. 2.4 Methotrexate Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Methotrexate Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Methotrexate Injection Revenue by Region
  3. 3.2.1 Global Methotrexate Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Methotrexate Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Methotrexate Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Methotrexate Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Methotrexate Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Methotrexate Injection Sales by Region
  9. 3.4.1 Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Methotrexate Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Methotrexate Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Methotrexate Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Methotrexate Injection Revenue by Manufacturers
  2. 4.1.1 Global Methotrexate Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Methotrexate Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Methotrexate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Methotrexate Injection Sales by Manufacturers
  6. 4.2.1 Global Methotrexate Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Methotrexate Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Methotrexate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Methotrexate Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Methotrexate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Methotrexate Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Methotrexate Injection Manufacturers, Product Type & Application
  13. 4.7 Global Methotrexate Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Methotrexate Injection Market CR5 and HHI
  16. 4.8.2 2025 Methotrexate Injection Tier 1, Tier 2, and Tier 3
5 Methotrexate Injection Market by Type
  1. 5.1 Global Methotrexate Injection Revenue by Type
  2. 5.1.1 Global Methotrexate Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Methotrexate Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Methotrexate Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Methotrexate Injection Sales by Type
  6. 5.2.1 Global Methotrexate Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Methotrexate Injection Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Methotrexate Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Methotrexate Injection Price by Type
6 Methotrexate Injection Market by Application
  1. 6.1 Global Methotrexate Injection Revenue by Application
  2. 6.1.1 Global Methotrexate Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Methotrexate Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Methotrexate Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Methotrexate Injection Sales by Application
  6. 6.2.1 Global Methotrexate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Methotrexate Injection Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Methotrexate Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Methotrexate Injection Price by Application
7 Company Profiles
  1. 7.1 Accord
  2. 7.1.1 Accord Company Information
  3. 7.1.2 Accord Business Overview
  4. 7.1.3 Accord Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Accord Methotrexate Injection Product Portfolio
  6. 7.1.5 Accord Recent Developments
  7. 7.2 Get Well Pharmaceutical
  8. 7.2.1 Get Well Pharmaceutical Company Information
  9. 7.2.2 Get Well Pharmaceutical Business Overview
  10. 7.2.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
  12. 7.2.5 Get Well Pharmaceutical Recent Developments
  13. 7.3 Hikma
  14. 7.3.1 Hikma Company Information
  15. 7.3.2 Hikma Business Overview
  16. 7.3.3 Hikma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hikma Methotrexate Injection Product Portfolio
  18. 7.3.5 Hikma Recent Developments
  19. 7.4 Fresenius Kabi
  20. 7.4.1 Fresenius Kabi Company Information
  21. 7.4.2 Fresenius Kabi Business Overview
  22. 7.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
  24. 7.4.5 Fresenius Kabi Recent Developments
  25. 7.5 Guangdong Lingnan Pharma
  26. 7.5.1 Guangdong Lingnan Pharma Company Information
  27. 7.5.2 Guangdong Lingnan Pharma Business Overview
  28. 7.5.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
  30. 7.5.5 Guangdong Lingnan Pharma Recent Developments
  31. 7.6 Hengrui Medicine
  32. 7.6.1 Hengrui Medicine Company Information
  33. 7.6.2 Hengrui Medicine Business Overview
  34. 7.6.3 Hengrui Medicine Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hengrui Medicine Methotrexate Injection Product Portfolio
  36. 7.6.5 Hengrui Medicine Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Methotrexate Injection Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Mylan
  44. 7.8.1 Mylan Company Information
  45. 7.8.2 Mylan Business Overview
  46. 7.8.3 Mylan Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mylan Methotrexate Injection Product Portfolio
  48. 7.8.5 Mylan Recent Developments
  49. 7.9 Qilu Pharmaceutical
  50. 7.9.1 Qilu Pharmaceutical Company Information
  51. 7.9.2 Qilu Pharmaceutical Business Overview
  52. 7.9.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
  54. 7.9.5 Qilu Pharmaceutical Recent Developments
  55. 7.10 Shanxi Pude Pharma
  56. 7.10.1 Shanxi Pude Pharma Company Information
  57. 7.10.2 Shanxi Pude Pharma Business Overview
  58. 7.10.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
  60. 7.10.5 Shanxi Pude Pharma Recent Developments
  61. 7.11 Sichuan Huiyu Pharma
  62. 7.11.1 Sichuan Huiyu Pharma Company Information
  63. 7.11.2 Sichuan Huiyu Pharma Business Overview
  64. 7.11.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
  66. 7.11.5 Sichuan Huiyu Pharma Recent Developments
  67. 7.12 Teva
  68. 7.12.1 Teva Company Information
  69. 7.12.2 Teva Business Overview
  70. 7.12.3 Teva Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Teva Methotrexate Injection Product Portfolio
  72. 7.12.5 Teva Recent Developments
  73. 7.13 Youcare Pharmaceutical Group
  74. 7.13.1 Youcare Pharmaceutical Group Company Information
  75. 7.13.2 Youcare Pharmaceutical Group Business Overview
  76. 7.13.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
  78. 7.13.5 Youcare Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Methotrexate Injection Market Size by Type
  2. 8.1.1 North America Methotrexate Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Methotrexate Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Methotrexate Injection Price by Type (2021-2032)
  5. 8.2 North America Methotrexate Injection Market Size by Application
  6. 8.2.1 North America Methotrexate Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Methotrexate Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Methotrexate Injection Price by Application (2021-2032)
  9. 8.3 North America Methotrexate Injection Market Size by Country
  10. 8.3.1 North America Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Methotrexate Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Methotrexate Injection Market Size by Type
  2. 9.1.1 Europe Methotrexate Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Methotrexate Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Methotrexate Injection Price by Type (2021-2032)
  5. 9.2 Europe Methotrexate Injection Market Size by Application
  6. 9.2.1 Europe Methotrexate Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Methotrexate Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Methotrexate Injection Price by Application (2021-2032)
  9. 9.3 Europe Methotrexate Injection Market Size by Country
  10. 9.3.1 Europe Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Methotrexate Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Methotrexate Injection Market Size by Type
  2. 10.1.1 China Methotrexate Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Methotrexate Injection Sales by Type (2021-2032)
  4. 10.1.3 China Methotrexate Injection Price by Type (2021-2032)
  5. 10.2 China Methotrexate Injection Market Size by Application
  6. 10.2.1 China Methotrexate Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Methotrexate Injection Sales by Application (2021-2032)
  8. 10.2.3 China Methotrexate Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Methotrexate Injection Market Size by Type
  2. 11.1.1 Asia Methotrexate Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Methotrexate Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Methotrexate Injection Price by Type (2021-2032)
  5. 11.2 Asia Methotrexate Injection Market Size by Application
  6. 11.2.1 Asia Methotrexate Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Methotrexate Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Methotrexate Injection Price by Application (2021-2032)
  9. 11.3 Asia Methotrexate Injection Market Size by Country
  10. 11.3.1 Asia Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Methotrexate Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Methotrexate Injection Market Size by Type
  2. 12.1.1 SAMEA Methotrexate Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Methotrexate Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Methotrexate Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Methotrexate Injection Market Size by Application
  6. 12.2.1 SAMEA Methotrexate Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Methotrexate Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Methotrexate Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Methotrexate Injection Market Size by Country
  10. 12.3.1 SAMEA Methotrexate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Methotrexate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Methotrexate Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Methotrexate Injection Value Chain Analysis
  2. 13.1.1 Methotrexate Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Methotrexate Injection Production Mode & Process
  6. 13.2 Methotrexate Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Methotrexate Injection Distributors
  9. 13.2.3 Methotrexate Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst